All News

Pfizer and BioNTech plan for submission to the FDA for an Emergency Use Authorization soon after the required safety milestone is achieved in mid-November for a promising novel COVID-19 vaccine candidate.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Sleep deficiency may impair the ability to cognitively filter intrusive memories and thoughts when confronted with reminders of them, according to a recent study.

The processes involving the high prevalence of diagnosis and over prescription undoubtedly play a role, but it is possible that the infra-diagnosis and lower prescription rates in men could be a factor, according to the study authors.

Janssen Pharmaceutical Companies submitted a supplemental New Drug Application (sNDA) to the FDA to expand the use of rivaroxaban in patients with peripheral artery disease.

Rite Aid announced the launch of its rebranded identity as part of its RxEvolution strategy, which is designed to transform the company into a leading whole health destination.

Novel COVID-19 vaccine uses nanoparticles instead of targeting the spike protein.

A final vote that assessed whether the findings from the EMERGE trial served as primary evidence for the efficacy of aducanumab in Alzheimer disease was 10–0 that the trial did not provide evidence.

Because influenza has a long seasonal cycle, the question regarding whether multiple influenza vaccinations, spaced throughout the season, could provide added protection has arisen.

Patients recently diagnosed with cancer are significantly more likely to quit smoking and remain tobacco-free if they receive frequent phone counseling over an extended period of time.

The drug combination of dapagliflozin and exenatide continues to stay effective without a loss of effect after 2 years of continual use in patients with type 2 diabetes (T2D), according to researchers at Thomas Jefferson University.

While most COVID-19 mutations do not affect disease severity, some may have made it more contagious.

By simulating inhalation, exhalation, coughs, and sneezes in the laboratory, the researchers discovered that non-woven fabrics used in most masks work well to demonstrate the concept.

Study shows that 61% of patients who either were not prescribed CPAP to treat their sleep apnea or were not adherent to their CPAP treatment were hospitalized with influenza.

Investigators demonstrated that protection from COVID-19 transmission increases with physical distancing in an approximately linear proportion.

A new breast cancer combination treatment may help patients with certain gene mutations, according to a study published in Molecular Cell.

Following tobacco’s introduction to Europe by the Spanish in the 16th century, European physicians embraced it exuberantly, dubbing it a panacea.

There are a number of ways to examine issues around supporting and developing pharmacy technicians, but perhaps the best way is to frame the issue using an organizational behavior lens.

A new device that delivers doses in tenths of a second rather than minutes may bypass adverse effects associated with traditional cancer radiation therapy.

Questions remain whether recovered COVID-19 patients who test positive are still contagious.

Further research is essential in order to determine the relationship between diabetes and COVID-19 and what impact glucose-lowering drugs may have.

Research suggests global access to COVID-19 vaccines is best for both global health and finances.

The greater effect on population-wide alcohol use could be tied to the effects of the COVID-19 pandemic, including widespread social disruption and isolation, limited social support and access to medical care, and negative domestic and global economic impacts.

The study found patients who received radiation 34 days or fewer before their infusion with CART-B cell maturation antigen (BCMA) cells did not have worse rates of severe cytokine release syndrome or neurotoxicity, which are 2 common adverse effects of the cellular therapy.

Inappropriately prescribed medications can increase the risk of serious adverse effects and increase the cost of care.

Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.

Camber Pharmaceuticals announces the launch of Zafirlukast tablets, which is the generic version of Accolate.

The current acute treatments for migraines have shown efficacy and safety, however, approximately one-third of people do not respond, cannot use these options due to contraindications, or report dissatisfaction in therapy.